Concentrations of phytanic acid and pristanic acid were measured in stored dried blood spots collected at neonatal screening from patients with peroxisomal disorders, and compared with concentrations in control blood spots. In blood spots from two patients with Zellweger syndrome both phytanic acid and pristanic acid concentrations were increasedbut their concentration ratio was normal. In the blood spot from a patient with rhizomelic chondrodysplasia punctata, the concentration of phytanic acid was increased, whereas pristanic acid was within the control range, resulting in a low pristanic acid/phytanic acid ratio.
Materials and Methods

Resufts
The calibration curves passed through the origin, indicating that neither phytanic acid nor pristanic acid was present in the filter paper. This disturbance is also reflected in the defective phytanic acid a-oxidation and pristanic acid a-oxidation, leading to accumulation of both acids in tissues and body fluids; however, the plasma concentration ratios are similar to those in control plasma (5). Phytanic acid in humans is exogenous and, in control subjects younger than 2 years, plasma values are age dependent (5 is of great importance. In RCDP the impairment of phytanic acid a-oxidation is more severe than in the Zellweger syndrome, and higher plasma concentrations of phytanic acid are measured at an earlier stage of life. This is also reflected in the finding of a higher phytanic acid concentration in the blood spot from the RCDP patient than in those from the patients with Zellweger syndrome. As with the results obtained for plasma from RCDP patients (5), the low pristanic acid/phytanic acid ratio in stored blood from such a patient indicates a disturbed phytanic acid a-oxidation, whereas pristanic acid (3-oxidation is normal.
In X-ALD a single enzyme defect exists, at VLCFA acyl-CoA synthetase (2 
